These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 34896016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genetically attenuated malaria parasites as vaccines.
    Vaughan AM, Kappe SHI.
    Expert Rev Vaccines; 2017 Aug; 16(8):765-767. PubMed ID: 28612631
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Challenge of developing anti-parasite vaccines in the tropics].
    Rogier C.
    Med Trop (Mars); 2007 Aug; 67(4):328-34. PubMed ID: 17926789
    [Abstract] [Full Text] [Related]

  • 6. Designer Parasites: Genetically Engineered Plasmodium as Vaccines To Prevent Malaria Infection.
    Goswami D, Minkah NK, Kappe SHI.
    J Immunol; 2019 Jan 01; 202(1):20-28. PubMed ID: 30587570
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of vaccines against human parasitic diseases: tools, current status and perspectives.
    Abath FG.
    Expert Opin Investig Drugs; 2000 Feb 01; 9(2):301-10. PubMed ID: 11060678
    [Abstract] [Full Text] [Related]

  • 10. Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.
    Gannavaram S, Dey R, Avishek K, Selvapandiyan A, Salotra P, Nakhasi HL.
    Front Immunol; 2014 Feb 01; 5():241. PubMed ID: 24904589
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Approaches and problems in vaccine development against leishmaniasis].
    Allahverdiyev A, Bağirova M, Cakir Koç R, Oztel ON, Elçıçek S, Ateş SC, Karaca TD.
    Turkiye Parazitol Derg; 2010 Feb 01; 34(2):122-30. PubMed ID: 20597059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Whole organism blood stage vaccines against malaria.
    Stanisic DI, Good MF.
    Vaccine; 2015 Dec 22; 33(52):7469-75. PubMed ID: 26428451
    [Abstract] [Full Text] [Related]

  • 15. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A, Barry AE, Dutta S, Remarque EJ, Beeson JG, Plowe CV.
    Vaccine; 2015 Dec 22; 33(52):7506-12. PubMed ID: 26475447
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vaccination against malaria with live parasites.
    Rénia L, Grüner AC, Mauduit M, Snounou G.
    Expert Rev Vaccines; 2006 Aug 22; 5(4):473-81. PubMed ID: 16989628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites.
    Finney OC, Keitany GJ, Smithers H, Kaushansky A, Kappe S, Wang R.
    Vaccine; 2014 Apr 17; 32(19):2135-8. PubMed ID: 24582635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.